Background In the United States, diabetes has increased rapidly, exceeding prior predictions. Projections of the future diabetes burden need to reflect changes in incidence, mortality, and demographics. We applied the most recent data available to develop an updated projection through 2060. Methods A dynamic Markov model was used to project prevalence of diagnosed diabetes among US adults by age, sex, and race (white, black, other). Incidence and current prevalence were from the National Health Interview Survey (NHIS) 1985–2014. Relative mortality was from NHIS 2000–2011 follow-up data linked to the National Death Index. Future population estimates including birth, death, and migration were from the 2014 Census projection. Results The proje...
BackgroundBoth incidence and mortality of diagnosed diabetes have decreased over the past decade. Ho...
Koyama AK, Cheng YJ, Brinks R, et al. Trends in lifetime risk and years of potential life lost from ...
One of the global targets for non-communicable diseases is to halt, by 2025, the rise in the age-sta...
Abstract Background In the United States, diabetes has increased rapidly, exceeding prior prediction...
Background People with diabetes can suffer from diverse complications that seriously erode quality o...
OBJECTIVE — To project the number of people with diagnosed diabetes in the U.S. through 2050, accoun...
Background: Diabetes is one of the leading causes of death and disability worldwide, and affects peo...
To forecast the number of U.S. individuals aged <20 years with type 1 diabetes mellitus (T1DM) or ty...
Objective To project the prevalence and number of youth with diabetes and trends in race and ethn...
Background: Diabetes is one of the leading causes of death and disability worldwide, and affects peo...
Tonnies T, Brinks R, Isom S, et al. Projections of Type 1 and Type 2 Diabetes Burden in the U.S. Pop...
BACKGROUND: Diabetes is one of the leading causes of death and disability worldwide, and affects peo...
Background Although diabetes is one of the most costly and rapidly increasing serious chronic diseas...
Objective To determine whether diabetes prevalence and incidence has remained flat or changed direct...
Since 1980, age-standardised diabetes prevalence in adults has increased, or at best remained unchan...
BackgroundBoth incidence and mortality of diagnosed diabetes have decreased over the past decade. Ho...
Koyama AK, Cheng YJ, Brinks R, et al. Trends in lifetime risk and years of potential life lost from ...
One of the global targets for non-communicable diseases is to halt, by 2025, the rise in the age-sta...
Abstract Background In the United States, diabetes has increased rapidly, exceeding prior prediction...
Background People with diabetes can suffer from diverse complications that seriously erode quality o...
OBJECTIVE — To project the number of people with diagnosed diabetes in the U.S. through 2050, accoun...
Background: Diabetes is one of the leading causes of death and disability worldwide, and affects peo...
To forecast the number of U.S. individuals aged <20 years with type 1 diabetes mellitus (T1DM) or ty...
Objective To project the prevalence and number of youth with diabetes and trends in race and ethn...
Background: Diabetes is one of the leading causes of death and disability worldwide, and affects peo...
Tonnies T, Brinks R, Isom S, et al. Projections of Type 1 and Type 2 Diabetes Burden in the U.S. Pop...
BACKGROUND: Diabetes is one of the leading causes of death and disability worldwide, and affects peo...
Background Although diabetes is one of the most costly and rapidly increasing serious chronic diseas...
Objective To determine whether diabetes prevalence and incidence has remained flat or changed direct...
Since 1980, age-standardised diabetes prevalence in adults has increased, or at best remained unchan...
BackgroundBoth incidence and mortality of diagnosed diabetes have decreased over the past decade. Ho...
Koyama AK, Cheng YJ, Brinks R, et al. Trends in lifetime risk and years of potential life lost from ...
One of the global targets for non-communicable diseases is to halt, by 2025, the rise in the age-sta...